CERS | CerusNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$2.34
-$0.02 (-0.85%)

Cerus (CERS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Nov 2025, but the two have been closing on each other and a death cross is projected within 10 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $2.34 vs 50 $2.45 / 200 $2.45
Projection
Death cross projected in 1 bar
Test
No active test
Last cross
Golden cross 4 Nov 2025 ยท projected 25 bars out ยท tested 3 bars

Weekly as of 30 Oct 16:00 ET

Price
between the two $2.28 vs 50 $2.38 / 200 $2.02
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 27 Jul 2026 ยท projected 18 bars out ยท tested 2 bars

4-hour as of 3 Nov 13:30 ET

Price
below both $2.29 vs 50 $2.32 / 200 $2.64
Projection
No cross projected
Test
No active test
Last cross
Death cross 1 Sep 2026 bar 1 ยท projected 15 bars out ยท tested 3 bars

Cross history

27
crosses on record since 2017
14 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
1 Sep 2026Death4-hour15 bars out3 bar cross test
week of 27 Jul 2026Golden moderateweekly18 bars out2 bar cross test
12 May 2026Golden4-hour18 bars outNot tested
26 Mar 2026Death4-hour28 bars outNot tested
4 Nov 2025Golden moderatedaily25 bars out3 bar cross test

About CERS

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$4.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.